KD bildar cancerbolag

Tillsätter vd som ska leda det nya dotterbolaget.

By Anna Sundström

February 14, 2012 12:00 AM

Karolinska Development har

bildat ett nytt dotterbolag, Kdev Oncology. Det nya bolaget kommer att samla fem-sex nya projektbolag inom onkologi, bland annat det redan existerande forskningsbolaget Akinion. Vd för det nybildade bolaget blir Carl Harald Janson.

Carl Harald Janson

kommer närmast från posten som investeringsansvarig på Karolinska Development. Han sitter i dag i styrelsen för fyra av bolagets portföljbolag: Axelar, Oncopeptides, Clanotech och Akinion.

{{ comments.count === 1 ? '1 comment' : comments.count > 1 ? '{0} comments'.replace('{0}', comments.count) : 'Write a comment' }}

By submitting the comment you accept the terms. See terms

Good comment behavior

Keep a good tone in your comments, avoid personal attacks and posts of marketing character. Apply only link on your comment if it is relevant to the debate.

Be aware that the debates are moderated by the portal's editorial team.

The comment has been created.

Your comment will not be visible until you activate it. In a few moments you will receive an email where you must click on a link to activate your comment.